Maternal exposure to lithium may up birth defects risk: Study

IANS  |  New York 

Babies born to women who used therapy to treat during their first-trimester of the could be at an elevated risk of developing major congenital malformations such as heart defects, finds a study.

The findings, published in The Lancet Psychiatry, showed that nearly one and one-half times as many babies exposed to during the first trimester experienced major malformations compared to the unexposed group (7.4 per cent compared with 4.3 per cent).

In addition, risk for neonatal hospital readmission was nearly doubled in lithium-exposed babies compared to the unexposed group (27.5 per cent versus 14.3 per cent).

However, exposure was not associated with complications or other delivery outcomes, such as pre-eclampsia, preterm birth, gestational diabetes, or low birth weight, the researchers said.

"Women should be informed on malformation risk in first-trimester exposed infants, but also about very high relapse risks for both during and during the postpartum period," said Veerle Bergink, at the Icahn School of at in New York City, US.

The team examined the risk of congenital malformations such as heart defects and in a meta-analysis of primary data from 727 lithium-exposed pregnancies compared to a control group of 21,397 pregnancies in mothers with a who were not taking lithium.

Lithium therapy is widely recommended as a first-line treatment for bipolar disorder, which affects approximately two per cent of the world's population. It also helps prevent and

"Given the well-documented effectiveness of lithium in reducing relapse in the perinatal period, some important clinical considerations are either to continue lithium in a lower dose during the first trimester or to restart lithium after the first trimester or immediately postpartum," Bergink said.

--IANS

rt/vd

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Tue, June 19 2018. 18:56 IST